Form 4 holding
Director
Kiniksa Pharmaceuticals International, plc
- Security class
- Class A Ordinary Share
- Shares / value
- 15,345
- Estimated value
- $738,861
- Report date
- 29 May 2026
- Price
- $48.15
- Ownership
- Direct
Kimberly J. Popovits - Director at Kiniksa Pharmaceuticals International, plc
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- KNSA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Kimberly J. Popovits since 23 Aug 2025
Reported holdings for Kimberly J. Popovits in Kiniksa Pharmaceuticals International, plc
Form 4 holding
Director
Kiniksa Pharmaceuticals International, plc
- Security class
- Share Option
- Shares / value
- 12,158
- Estimated value
- Report date
- 29 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
Form 4 holding
Director
Kiniksa Pharmaceuticals International, plc
- Security class
- Restricted Share Units
- Shares / value
- 0
- Estimated value
- Report date
- 29 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
Transaction history for Kimberly J. Popovits in Kiniksa Pharmaceuticals International, plc
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.